imbruvica 140mg/cap καψακιο, σκληρο
janssen-cilag intern. nv.,belgium (0000003234) turnhoutseweg, 30, b-2340 beerse, - ibrutinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 140mg/cap - 0936563961 ibrutinib 140.000000 mg - ibrutinib
imbruvica 560mg/ταβ επικαλυμμενο με λεπτο υμενιο δισκιο
janssen-cilag intern. nv.,belgium (0000003234) turnhoutseweg, 30, b-2340 beerse, - ibrutinib - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 560mg/ΤΑΒ - 0936563961 ibrutinib 140.000000 mg - ibrutinib
imbruvica 140mg/τaβ επικαλυμμενο με λεπτο υμενιο δισκιο
janssen-cilag intern. nv.,belgium (0000003234) turnhoutseweg, 30, b-2340 beerse, - ibrutinib - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 140mg/ΤaΒ - 0936563961 ibrutinib 140.000000 mg - ibrutinib
imbruvica 280mg/ταβ επικαλυμμενο με λεπτο υμενιο δισκιο
janssen-cilag intern. nv.,belgium (0000003234) turnhoutseweg, 30, b-2340 beerse, - ibrutinib - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 280mg/ΤΑΒ - 0936563961 ibrutinib 280.000000 mg - ibrutinib
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
cleron 250mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - clarithromycin - film coated tablets - 250mg - clarithromycin (8000001318) 250mg - clarithromycin
venoruton tab 500mg/tab
stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - oxerutins - tab (ΔΙΣΚΙΟ) - 500mg/tab - oxerutins 500mg - bioflavonoids - bioflavonoids
venoruton ef.tab 1000mg/tab
stada arzneimittel ag, germany stadastrasse 2 - 18, 61118 bad vilbel - oxerutins - ef.tab (ΑΝΑΒΡΑΖΟΝ ΔΙΣΚΙΟ) - 1000mg/tab - oxerutins 1.000mg - bioflavonoids - bioflavonoids
venoruton 500mg/tab αναβραζον δισκιο
glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΪΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. gsk ch ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΕ (0000011397) Λε - oxerutins - ΑΝΑΒΡΑΖΟΝ ΔΙΣΚΙΟ - 500mg/tab - ineof00260 oxerutins 500.000000 mg - bioflavonoids - bioflavonoids
imbruvica 140mg/cap καψακιο, σκληρο
ΙΦΕΤ ΑΕ - ibrutinib - ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ - 140mg/cap - 0936563961 - ibrutinib - 140.000000 mg - protein kinase inhibitors